{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} The Effects of Dexamethasone in Diabetic Patients Undergoing Primary Total Joint Arthroplasty

Activity Steps

Description

This article has been approved by the Orthopaedic Nurses Certification Board for Category A credit toward recertification as an ONC.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Summarize existing evidence informing the use of dexamethasone with patients undergoing joint arthroplasty.
  2. Evaluate the results of this study of the effects of dexamethasone on postoperative blood glucose, PJI, and 90-day hospital returns in patients with diabetes following TJA.
  3. Discern the implications of the study results for clinical practice and further research.

Learning Outcomes

Healthcare providers will demonstrate knowledge of a study that examined the effects of dexamethasone on various postoperative variables in patients with diabetes following total joint arthroplasty (TJA) by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $15.00

Credits:

  • ANCC 1.5 CH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.







Test Code: ON0921C
Published: Sep/Oct 2021
Expires: 9/6/2024
Required Passing Score: 8/10 (80%)
Authors: Margaret M. Harding, MSN, AGPCNP-BC, RNFA, CPAN; Sonia E. Xavier, MSN, MPH, ACNP-C; Thorsten M. Seyler, MD, PhD; Sean P. Ryan, MD